vs
GE医疗（CCRN）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是BRC Group Holdings, Inc.的1.3倍（$236.8M vs $188.3M），BRC Group Holdings, Inc.净利率更高（47.9% vs -35.0%，领先83.0%），BRC Group Holdings, Inc.同比增速更快（-21.9% vs -23.6%），过去两年BRC Group Holdings, Inc.的营收复合增速更高（-15.4% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
CCRN vs RILY — 直观对比
营收规模更大
CCRN
是对方的1.3倍
$188.3M
营收增速更快
RILY
高出1.8%
-23.6%
净利率更高
RILY
高出83.0%
-35.0%
两年增速更快
RILY
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $188.3M |
| 净利润 | $-82.9M | $90.3M |
| 毛利率 | — | 79.5% |
| 营业利润率 | -30.2% | 32.3% |
| 净利率 | -35.0% | 47.9% |
| 营收同比 | -23.6% | -21.9% |
| 净利润同比 | -2109.7% | 1710.8% |
| 每股收益（稀释后） | $-2.56 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNRILY
| Q4 25 | $236.8M | $188.3M | ||
| Q3 25 | $250.1M | $215.3M | ||
| Q2 25 | $274.1M | $188.2M | ||
| Q1 25 | $293.4M | $197.2M | ||
| Q4 24 | $309.9M | $241.0M | ||
| Q3 24 | $315.1M | $225.5M | ||
| Q2 24 | $339.8M | $256.0M | ||
| Q1 24 | $379.2M | $263.4M |
净利润CCRNRILY
| Q4 25 | $-82.9M | $90.3M | ||
| Q3 25 | $-4.8M | $91.1M | ||
| Q2 25 | $-6.7M | $139.5M | ||
| Q1 25 | $-490.0K | $-10.0M | ||
| Q4 24 | $-3.8M | $-5.6M | ||
| Q3 24 | $2.6M | $-284.4M | ||
| Q2 24 | $-16.1M | $-433.6M | ||
| Q1 24 | $2.7M | $-49.2M |
毛利率CCRNRILY
| Q4 25 | — | 79.5% | ||
| Q3 25 | 20.4% | 83.7% | ||
| Q2 25 | 20.4% | 81.3% | ||
| Q1 25 | 20.0% | 81.4% | ||
| Q4 24 | — | 79.8% | ||
| Q3 24 | 20.4% | 82.1% | ||
| Q2 24 | 20.8% | 84.5% | ||
| Q1 24 | 20.4% | 85.3% |
营业利润率CCRNRILY
| Q4 25 | -30.2% | 32.3% | ||
| Q3 25 | -2.4% | 30.4% | ||
| Q2 25 | -2.1% | 5.7% | ||
| Q1 25 | -0.3% | -31.2% | ||
| Q4 24 | -1.1% | -69.2% | ||
| Q3 24 | 0.9% | -36.4% | ||
| Q2 24 | -5.7% | -90.8% | ||
| Q1 24 | 0.8% | -6.1% |
净利率CCRNRILY
| Q4 25 | -35.0% | 47.9% | ||
| Q3 25 | -1.9% | 42.3% | ||
| Q2 25 | -2.4% | 74.1% | ||
| Q1 25 | -0.2% | -5.1% | ||
| Q4 24 | -1.2% | -2.3% | ||
| Q3 24 | 0.8% | -126.1% | ||
| Q2 24 | -4.7% | -169.4% | ||
| Q1 24 | 0.7% | -18.7% |
每股收益（稀释后）CCRNRILY
| Q4 25 | $-2.56 | $2.78 | ||
| Q3 25 | $-0.15 | $2.91 | ||
| Q2 25 | $-0.20 | $4.50 | ||
| Q1 25 | $-0.02 | $-0.39 | ||
| Q4 24 | $-0.13 | $-0.01 | ||
| Q3 24 | $0.08 | $-9.39 | ||
| Q2 24 | $-0.47 | $-14.35 | ||
| Q1 24 | $0.08 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $322.8M | $-171.5M |
| 总资产 | $449.0M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNRILY
| Q4 25 | $108.7M | $226.6M | ||
| Q3 25 | $99.1M | $184.2M | ||
| Q2 25 | $81.2M | $267.4M | ||
| Q1 25 | $80.7M | $138.3M | ||
| Q4 24 | $81.6M | $146.9M | ||
| Q3 24 | $64.0M | $159.2M | ||
| Q2 24 | $69.6M | $236.9M | ||
| Q1 24 | $5.2M | $190.7M |
总债务CCRNRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CCRNRILY
| Q4 25 | $322.8M | $-171.5M | ||
| Q3 25 | $408.1M | $-260.5M | ||
| Q2 25 | $412.2M | $-351.7M | ||
| Q1 25 | $418.2M | $-496.8M | ||
| Q4 24 | $419.0M | $-488.2M | ||
| Q3 24 | $424.7M | $-497.6M | ||
| Q2 24 | $433.3M | $-218.3M | ||
| Q1 24 | $462.4M | $228.4M |
总资产CCRNRILY
| Q4 25 | $449.0M | $1.7B | ||
| Q3 25 | $538.2M | $1.7B | ||
| Q2 25 | $553.8M | $1.5B | ||
| Q1 25 | $576.2M | $1.5B | ||
| Q4 24 | $589.3M | $1.8B | ||
| Q3 24 | $597.4M | $2.2B | ||
| Q2 24 | $602.9M | $3.2B | ||
| Q1 24 | $648.4M | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | — |
| 自由现金流率自由现金流/营收 | 6.8% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.29× |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势，按日历期对齐
经营现金流CCRNRILY
| Q4 25 | $18.2M | $26.2M | ||
| Q3 25 | $20.1M | $-60.6M | ||
| Q2 25 | $4.2M | $-25.6M | ||
| Q1 25 | $5.7M | $184.0K | ||
| Q4 24 | $24.2M | $-2.7M | ||
| Q3 24 | $7.5M | $19.5M | ||
| Q2 24 | $82.4M | $111.5M | ||
| Q1 24 | $6.0M | $135.4M |
自由现金流CCRNRILY
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.3M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $79.6M | — | ||
| Q1 24 | $3.8M | — |
自由现金流率CCRNRILY
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 1.0% | — |
资本支出强度CCRNRILY
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.6% | — |
现金转化率CCRNRILY
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
